针对多发性骨髓瘤的BCMA向疗法:进展,挑战和未来前景
Ruhul Amin1, Biplab Kumar Dey2, Ronald Darwin3
1Rahman Institute of Pharmaceutical Sciences and Research (RIPSR), Kamarkuchi, Kamrup (M), Tepesia, Assam, 782402, India.
Medical oncology (Northwood, London, England)
|May 8, 2025
概括
针对B细胞成熟抗原 (BCMA) 的新疗法,包括CAR T细胞疗法和双特异性抗体,在治疗多发性骨髓瘤 (MM) 方面表现有前途. 目前正在进行的研究旨在提高疗效和减少副作用,以改善患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 多发性骨髓瘤 (MM) 是一种血细胞恶性瘤,在历史上治疗持续缓解的治疗选择有限.
- B细胞成熟抗原 (BCMA) 对髓瘤细胞的存活和增殖至关重要,使其成为关键的治疗点.
研究的目的:
- 对多发性骨髓瘤的BCMA向治疗方法的最新进展进行批判性评估.
- 评估新兴治疗方法的疗效,可访问性和未来方向,如CAR T细胞疗法和双特异性抗体.
主要方法:
- 对目前的临床试验和研究的综合性审查BCMA向疗法的研究.
- 对化学抗原受体 (CAR) T细胞疗法和针对BCMA的双特异性抗体的分析.
主要成果:
- 针对BCMA的疗法在MM中表现出显著的疗效,一些患者实现了完全缓解.
- 这些治疗与不良反应有关,包括细胞因子释放综合征和神经毒性.
结论:
- 针对BCMA的疗法代表了MM治疗的重大进步,为长期缓解和治愈提供了潜力.
- 进一步的研究对于优化治疗效果,最大限度地减少不良事件和提高患者可访问性至关重要.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.7K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
